Luis A Zuniga

Title: The Innovative Contributions of Luis A. Zuniga

Introduction

Luis A. Zuniga is a notable inventor based in Mountain View, California. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for cancer treatment. With a total of four patents to his name, Zuniga's work is recognized for its potential impact on medical therapies.

Latest Patents

Among his latest patents, Zuniga has developed anti-ILT4 antibodies and antigen-binding fragments. These inventions provide antibodies that specifically bind to ILT4 (immunoglobulin-like transcript 4) and can be combined with other antibodies, such as anti-PD1 antibodies. The methods of use for these antibodies include treating or preventing cancer in subjects, showcasing their therapeutic potential.

Career Highlights

Zuniga has worked with prominent companies in the biotechnology sector, including Merck Sharp & Dohme Corporation and Agenus Inc. His experience in these organizations has contributed to his expertise in developing innovative solutions in the field of immunotherapy.

Collaborations

Throughout his career, Zuniga has collaborated with talented professionals, including Barbara Joyce-Shaikh and Andrea Claudia Schuster. These collaborations have likely enriched his research and development efforts.

Conclusion

Luis A. Zuniga's contributions to biotechnology, particularly in the area of cancer treatment, highlight his role as an influential inventor. His patents and collaborations reflect a commitment to advancing medical science and improving patient outcomes.